C
Caris Life Sciences, Inc. (CAI)
NMS – Real vaqt narxi. Valyuta: USD
22.26
-0.88 (-3.80%)
Yopilishda: Aug 12, 2026, 4:00 PM EDT
22.19
-0.07 (-0.31%)
Bozordan keyin: Aug 12, 2026, 6:08 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NMS – Real vaqt narxi. Valyuta: USD
22.26
-0.88 (-3.80%)
Yopilishda: Aug 12, 2026, 4:00 PM EDT
22.19
-0.07 (-0.31%)
Bozordan keyin: Aug 12, 2026, 6:08 PM EDT
Caris Life Sciences, Inc., sun'iy intellektga asoslangan TechBio kompaniyasi, AQSh va xalqaro miqyosda molekulyar profiling xizmatlarini taqdim etadi. U molekulyar ma'lumotlar va sun'iy intellekt/mashinani o'rganish algoritmlaridan foydalangan holda sog'liqni saqlashni o'zgartirish uchun yechimlarni ishlab chiqadi va tijoratlashtiradi. Kompaniyaning molekulyar razvedka mahsulotlari portfeliga MI Profile Platform, butun ekzom sekvenslash (WES)/butun transkriptom sekvenslash (WTS) to'qimalarga asoslangan molekulyar profiling yechimlari; Caris Assure Platform WES/WTS qonga asoslangan molekulyar profiling yechimlari; Precision Whole Genome Platform, butun genom sekvenslash (WGS) qon va to'qimalarga asoslangan profiling yechimlari; va Caris Detect, WGSga asoslangan ko'p saratonni erta aniqlash yechimi; Caris WGS MRD WGS va raqamli tomchi polimeraza zanjiri reaksiyasi asosidagi minimal qoldiq kasallik yechimi; va Caris ChromoSeq, gematologik saratonlarda terapiya tanlovi uchun WGS va WTS asosidagi tahlil kiradi. Shuningdek, u biofarmatsevtika mijozlariga laboratoriya yetkazib berish, strategik ma'lumotlar va tadqiqot xizmatlarini o'z ichiga olgan pharma tadqiqot va ishlanmalar xizmatlarini taklif etadi. Kompaniya o'zining aniq onkologiya yechimlarini shifoxonalar, muassasalar va bemorlar kabi mijozlarga taqdim etadi. Kompaniya 2008-yilda tashkil etilgan va Irving, Texasda joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. David Spetzler M.B.A., M.S., Ph.D. | President |
| Dr. David Dean Halbert M.D. | Chairman, CEO & Founder |
| Dr. Milan Radovich Ph.D. | Senior VP & Chief Scientific Officer |
| Dr. Valeriy Domenyuk | Senior VP & CTO |
| Mr. Brian J. Brille J.D. | Executive Vice Chairman & Executive VP |
| Mr. J. Russel Denton | Senior VP, General Counsel & Secretary |
| Mr. Jeremy O'Brien | Senior Vice President of Human Resources & Chief Compliance Officer |
| Mr. Jon Mark Harmon | Senior VP & Chief Operations Officer |
| Mr. Luke Power | Senior VP, CFO & Chief Accounting Officer |
| Mr. Narendra Chokshi | Senior Vice President of Corporate Development |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-08-05 | 10-Q | cai-20260630.htm |
| 2026-06-16 | 8-A12B | tm2617492d1_8a12b.htm |
| 2026-06-05 | 8-K | cai-20260604.htm |
| 2026-05-08 | 10-Q | cai-20260331.htm |
| 2026-05-07 | 8-K | cai-20260507.htm |
| 2026-04-23 | DEFA14A | additionaldefinitiveproxys.htm |
| 2026-04-23 | DEF 14A | cai-20260423.htm |
| 2026-04-23 | ARS | carislifesciencesincars422.pdf |
| 2026-04-02 | 8-K | cai-20260401.htm |
| 2026-03-03 | 10-K | cai-20251231.htm |